<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-id journal-id-type="pmc-domain-id">1579</journal-id><journal-id journal-id-type="pmc-domain">scirep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12474866</article-id><article-id pub-id-type="pmcid-ver">PMC12474866.1</article-id><article-id pub-id-type="pmcaid">12474866</article-id><article-id pub-id-type="pmcaiid">12474866</article-id><article-id pub-id-type="pmid">41006372</article-id><article-id pub-id-type="doi">10.1038/s41598-025-04735-5</article-id><article-id pub-id-type="publisher-id">4735</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Mechanisms of <italic toggle="yes">Saposhnikovia divaricata</italic> in attenuating NaAsO<sub>2</sub>-induced neural injury via the PI3K/AKT pathway</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Gu</surname><given-names initials="D">Dan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Chen</surname><given-names initials="XL">Xian-Li</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>He</surname><given-names initials="HL">Heng-Lin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Xia</surname><given-names initials="M">Mei</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Huang</surname><given-names initials="JY">Jin-Ying</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>He</surname><given-names initials="GH">Guang-Hui</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="XY">Xin-Yu</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="YY">Yan-Yu</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kang</surname><given-names initials="WR">Wen-Run</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sun</surname><given-names initials="BF">Bao-Fei</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="XH">Xiao-Hong</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Zhou</surname><given-names initials="W">Wei</given-names></name><address><email>drwzhou@126.com</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Zhuo</surname><given-names initials="XL">Xian-Lu</given-names></name><address><email>zhuoxianlu@gmc.edu.cn</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Pan</surname><given-names initials="JG">Ji-Gang</given-names></name><address><email>jgpan@gmc.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/035y7a716</institution-id><institution-id institution-id-type="GRID">grid.413458.f</institution-id><institution-id institution-id-type="ISNI">0000 0000 9330 9891</institution-id><institution>Department of Physiology, School of Basic Medical Sciences, </institution><institution>Guizhou Medical University, </institution></institution-wrap>No. 6 Ankang Avenue, Gui&#8217;an New District, Guiyang, 561113 Guizhou China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02kstas42</institution-id><institution-id institution-id-type="GRID">grid.452244.1</institution-id><institution>Affiliated Hospital of Guizhou Medical University, </institution></institution-wrap>Guiyang, 550004 Guizhou China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/035y7a716</institution-id><institution-id institution-id-type="GRID">grid.413458.f</institution-id><institution-id institution-id-type="ISNI">0000 0000 9330 9891</institution-id><institution>Department of Pharmaceutical Analysis, School of Pharmacy, </institution><institution>Guizhou Medical University, </institution></institution-wrap>No. 6 Ankang Avenue, Gui&#8217;an New District, Guiyang, 561113 Guizhou China </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/035y7a716</institution-id><institution-id institution-id-type="GRID">grid.413458.f</institution-id><institution-id institution-id-type="ISNI">0000 0000 9330 9891</institution-id><institution>Key Laboratory of Human Brain Bank for Functions and Diseases of Department of Education of Guizhou Province, </institution><institution>Guizhou Medical University, </institution></institution-wrap>Guiyang, 561113 Guizhou China </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>15</volume><issue-id pub-id-type="pmc-issue-id">478255</issue-id><elocation-id>33303</elocation-id><history><date date-type="received"><day>14</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>28</day><month>5</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>26</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>28</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-28 14:25:15.427"><day>28</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="41598_2025_Article_4735.pdf"/><abstract id="Abs1"><p id="Par1"><italic toggle="yes">Saposhnikovia divaricata</italic> (<italic toggle="yes">S. divaricata</italic>) has demonstrated significant efficacy in mitigating arsenic poisoning. However, its protective effects of <italic toggle="yes">S. divaricata</italic> against NaAsO<sub>2</sub>-induced neural injury remain unclear. Based on network pharmacology, through intersection analysis, the common targets of the effective ingredients and targets of <italic toggle="yes">S. divaricata</italic> were selected from the TCMSP database, and the targets related to neural injury and arsenic toxicity were selected from the GeneCards database. Subsequently, protein&#8211;protein interaction (PPI),&#160;GO and KEGG enrichment analyses were carried out. We validated the PI3K/AKT pathway in vitro by assessing drug effects by CCK8 assays, flow cytometry, Western blot, and RT-qPCR. The PI3K/AKT pathway was screened by using network pharmacology, and AKT1 was identified as a core target via topological analysis using the degree algorithm among 45 potential targets derived from 72 traditional Chinese medicine targets, 9717 nerve injury targets, and 2224 arsenic toxicity targets. Molecular docking revealed that 9 active components of <italic toggle="yes">S. divaricata</italic> interacted with AKT1. In vitro experiments revealed that <italic toggle="yes">S. divaricata</italic> effectively mitigated neural injury by increasing cell viability, antioxidant activity and Bcl2 level while decreasing the apoptosis rate and the levels of Bax, Caspase8, Caspase3 and Cleaved-caspase3 in HT22 cells exposed to NaAsO<sub>2</sub>. The ratios of p-PI3K/PI3K and p-AKT/AKT were further increased by <italic toggle="yes">S. divaricata</italic> as well as Nrf2 expression. Our findings indicated that <italic toggle="yes">S. divaricata</italic> exerted multicomponent, multitarget and multipathway protection against NaAsO<sub>2</sub>-induced neurotoxicity. These effects were related to the antioxidant and antiapoptotic properties of <italic toggle="yes">S. divaricata</italic>, which might be achieved by activating the PI3K/AKT signaling pathway.</p><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1038/s41598-025-04735-5.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd><italic toggle="yes">Saposhnikovia divaricata</italic></kwd><kwd>Sodium arsenite</kwd><kwd>Nerve injury</kwd><kwd>Network pharmacology</kwd><kwd>PI3K/AKT pathway</kwd></kwd-group><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Cell biology</kwd><kwd>Drug discovery</kwd><kwd>Neuroscience</kwd><kwd>Physiology</kwd></kwd-group><funding-group><award-group><funding-source><institution>the Department of Education of Guizhou Province</institution></funding-source><award-id>Guizhou Teaching and Technology [2023]015</award-id><principal-award-recipient><name name-style="western"><surname>Sun</surname><given-names>Bao-Fei</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>the College Students&#8217; innovation and entrepreneurship training program of Guizhou Province</institution></funding-source><award-id>S202210660077</award-id><award-id>S202210660078</award-id><principal-award-recipient><name name-style="western"><surname>Liu</surname><given-names>Xiao-Hong</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Ji-Gang</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Guizhou Provincial Science and Technology Support Project</institution></funding-source><award-id>No. 2021-General 415</award-id><principal-award-recipient><name name-style="western"><surname>Zhou</surname><given-names>Wei</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>the National Natural Science Foundation of China</institution></funding-source><award-id>31960188</award-id><principal-award-recipient><name name-style="western"><surname>Pan</surname><given-names>Ji-Gang</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">Arsenic is a nonmetallic element that is present extensively within natural rocks, soils, and aquatic environments<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Research has demonstrated that arsenic can accumulate extensively within the brain via the blood&#8210;brain barrier, leading to mitochondrial membrane instability and subsequent energy depletion, thereby exerting potent neurotoxic effects<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup>. Prolonged exposure to high levels of arsenic compounds may induce peripheral neural injury and developmental disorders related to cognitive and behavioral aspects in both humans and animals<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>. In contemporary medical practice, sodium dithio-propyl sulfonate (DMPS) is known for its substantial arsenic-detoxifying properties and is frequently employed as a specific therapeutic agent for arsenic intoxication<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref></sup>. Despite its utility, the treatment is associated with adverse effects such as nausea, tachycardia, and vertigo, along with allergic reactions, including rashes, shivering, fever, and even anaphylactic shock and exfoliative dermatitis, prompting a search for safer and more healthful substitutes<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. As a traditional Chinese medicine, <italic toggle="yes">Saposhnikovia divaricata</italic> (<italic toggle="yes">S. divaricata</italic>) has pronounced anti-inflammatory, immunomodulatory, and antiviral properties and is clinically applied for the management of liver and cardiac injuries induced by arsenic poisoning<sup><xref ref-type="bibr" rid="CR9">9</xref>&#8211;<xref ref-type="bibr" rid="CR11">11</xref></sup>. Notably, there are no reports in the literature on the protection of <italic toggle="yes">S. divaricata</italic> against arsenic-induced neuronal damage.</p><p id="Par6">Network pharmacology represents an emerging academic field that elucidates the intricate interplay among drugs, their targets, biochemical pathways, and associated diseases, which is instrumental in the discovery of novel therapeutics, the prediction of therapeutic targets, and the elucidation of pharmacological mechanisms of action<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>.</p><p id="Par7">In the present investigation, network pharmacology was used to identify the pivotal targets associated with <italic toggle="yes">S. divaricata</italic> intervention and NaAsO<sub>2</sub>-induced neural injury in HT22 cells. A model of arsenic exposure and <italic toggle="yes">S. divaricata</italic> intervention was subsequently established in vitro, and the effects of NaAsO<sub>2</sub> and <italic toggle="yes">S. divaricata</italic> on HT22 cells were assessed. Finally, the involved signaling pathways were further explored via the CCK8 assay, Western blot analysis, and flow cytometry techniques.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Bioinformatics research</title><sec id="Sec4"><title>Acquisition of <italic toggle="yes">Saposhnikovia divaricata</italic> targets</title><p id="Par8">Using the TCMSP (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://old.tcmsp-e.com/tcmsp.php">https://old.tcmsp-e.com/tcmsp.php</ext-link>) database<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>, we applied screening criteria of oral bioavailability (OB)&#8201;&#8805;&#8201;30% and compound drug-likeness (DL)&#8201;&#8805;&#8201;0.18 as screening conditions to identify active compounds, including (2R, 3R) 3-(4-hydroxy-3-methoxy-phenyl)-5-methoxy-2-methyl-2,3-dihydropyrano [5,6-h][1,4]benzodioxin-9-one (chloramphenicol A), 11-hydroxysec-o-beta-d-glucosylhamaudol_qt, anomalin, divaricatacid, divaricatol, Ammidin, ledebouriellol, phelloptorin, 5-O-Methylvisamminol, Phellopterin, sitosterol, wogonin, beta sitosterol, Mandenol, isoimperatorin, Prangenidin, methyl icosa-11,14-dienoate, and Decursin from <italic toggle="yes">S. divaricata</italic>. The identified active ingredients were subsequently imported into the PubChem database (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/">https://pubchem.ncbi.nlm.nih.gov/</ext-link>)<sup><xref ref-type="bibr" rid="CR15">15</xref></sup> to retrieve their SMILES numbers or chemical structural formulas. SMILES numbers or chemical structural formulas of active ingredients were imported into the SwissTarget prediction database (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.swisstargetprediction.ch/">http://www.swisstargetprediction.ch/</ext-link>)<sup><xref ref-type="bibr" rid="CR16">16</xref></sup> to ascertain potential targets associated with traditional Chinese medicine drugs.</p></sec><sec id="Sec5"><title>Acquisition of genes related to arsenic poisoning and nerve injury</title><p id="Par9">We employed &#8220;arsenic&#8221; and &#8220;nerve injury&#8221; as search terms within the GeneCards database (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.genecards.org/">https://www.genecards.org/</ext-link>)<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> to extract genes related to arsenic poisoning and nerve injury.</p></sec><sec id="Sec6"><title>Construction of the component-target disease network</title><p id="Par10">The targets related to the <italic toggle="yes">S. divaricata</italic>, along with those linked to arsenic and nerve injury, were input into the Venny website (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://bioinfogp.cnb.csic.es/tools/venny/">https://bioinfogp.cnb.csic.es/tools/venny/</ext-link>)<sup><xref ref-type="bibr" rid="CR18">18</xref></sup> for common targets. The interaction targets were constructed via the String database (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://cn.string-db.org/">https://cn.string-db.org/</ext-link>)<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> alongside Cytoscape version 3.7.2 software for protein&#8210;protein interaction analysis; this facilitated the extraction of significant indicators for subsequent experiments through PPI network scoring analysis in Cytoscape 3.7.2 software while employing the NetworkAnalyzer plugin for topological assessment, yielding metrics such as degree centrality and betweenness centrality values.</p></sec><sec id="Sec7"><title>Enrichment analysis of active ingredients-disease intersection targets</title><p id="Par11">The clusterProfiler package was used to perform gene ontology (GO) enrichment analyses on intersection targets between active ingredients and differentially expressed genes across three levels: biological process (BP), cellular component (CC), and molecular function (MF), which also included Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment assessments.</p></sec><sec id="Sec8"><title>Construction of a protein interaction network diagram for PI3K/AKT pathway analysis</title><p id="Par12">Cytoscape 3.7.2 software was used to generate a PPI network diagram illustrating protein interactions; additionally, the CytoHubba tool was used for degree value calculations, leading us to identify core target proteins of this pathway.</p></sec><sec id="Sec9"><title>Molecular docking</title><p id="Par13">This project aimed to link with the PubChem database to download 3D structures corresponding to effective components derived from <italic toggle="yes">S. divaricata</italic>; candidate target protein structures along with ligand configurations were sourced from the PDB database (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.rcsb.org/">https://www.rcsb.org/</ext-link>)<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. Subsequently, molecular docking simulations were performed via AutoDock Tools software, followed by visualization via PyMOL software to effectively demonstrate the docking results.</p></sec></sec><sec id="Sec10"><title>Experimental verification</title><sec id="Sec11"><title>Medications and reagents</title><p id="Par14"><italic toggle="yes">Saposhnikovia divaricata</italic> (HPLC purity&#8201;&gt;&#8201;98%) was commercially purchased from Beijing Tongrentang Pharmaceutical Co., Ltd. (Beijing, China). Classification and identification were conducted by Professor Shaohuan Liu (School of Pharmacy, Guizhou Medical University) through macroscopic and microscopic characterization. The voucher specimen (No.2021110701) has been stored in the Herbarium of the School of Basic Medicine, Guizhou Medical University (Room 5&#8211;9 of the Physiology Laboratory), and was obtained through licensed commercial channels; sodium arsenite NaAsO<sub>2</sub> (HPLC&#8201;&gt;&#8201;98%) was acquired from Shanghai Sigma High Tech Co., Ltd. (Shanghai, China); fetal bovine serum, DMEM and penicillin/streptomycin were purchased from Thermo Fisher Scientific (Massachusetts, USA); polyclonal antibodies against PI3K, p-PI3K, AKT, p-AKT, Caspase3, Cleaved-caspase3, Caspase8, Bcl2, and Bax and GAPDH polyclonal antibodies were sourced from Wuhan Sanying Biotechnology Co., Ltd. (Wuhan, China); a cell apoptosis detection kit was provided by Kaiji Biological Company (Nanjing, China); a reactive oxygen species detection kit was obtained from Biyuntian Biotechnology Co., Ltd. (Shanghai, China); and a trace reduced glutathione (GSH) determination kit was obtained from Nanjing Jiancheng Biotechnology Research Institute (Nanjing, China).</p></sec><sec id="Sec12"><title>Cell culture</title><p id="Par15">The mouse hippocampal neuron cell line HT22 was obtained from Wuhan Punosai Biotechnology Co., Ltd. (Wuhan, China). Subsequently, the HT22 cells were cultivated in low-glucose medium supplemented with 10% fetal bovine serum and 1% penicillin&#8210;streptomycin and placed in a 37&#160;&#176;C, 5% CO<sub>2</sub> incubator. The culture medium was changed daily, and the cells were passaged or cryopreserved when the confluence reached approximately 80&#8211;90%.</p></sec><sec id="Sec13"><title>CCK8 assay</title><p id="Par16">When a standard 96-well plate was used, 8000 cells were inoculated into each well with 100 &#181;L of culture medium, and the culture plate was subsequently placed in a culture incubator (37&#160;&#176;C, 5% CO<sub>2</sub>) for 12&#8211;24&#160;h. Following cell adhesion to the plate surface, different treatments were administered for an additional 24&#160;h. Ten microliters of CCK8 reagent was added to each well and incubated for 2&#160;h before the absorbance was measured at a wavelength of 450&#160;nm.</p></sec><sec id="Sec14"><title>Reactive oxygen species (ROS) assay</title><p id="Par17">Well-cultured HT22 cells were inoculated in a six-well plate; when the cell density reached approximately 70-80%, different treatments were applied for 24&#160;h: control, NaAsO<sub>2</sub> (12.5 &#181;M) and NaAsO<sub>2</sub>&#8201;+&#8201;<italic toggle="yes">S. divaricata</italic> (12.5 &#181;M&#8201;+&#8201;400&#160;&#181;g/mL). The culture medium was removed after 24&#160;h, and the cells were washed twice with PBS. One milliliter of serum-free culture medium was added to each well, 1 &#181;L of DCFH-DA probe was added to each well, and the mixture was incubated for 20&#160;min in a dark incubator. Then, the cells were collected, and 300 &#181;L of PBS was added, after which the mixture was resuspended and tested by flow cytometry. The experiment was repeated three times for different batches of cells.</p></sec><sec id="Sec15"><title>Glutathione (GSH) assay</title><p id="Par18">After the cells were washed twice with PBS, they were collected via low-speed centrifugation and resuspended in 0.3&#8211;0.5&#160;L of isotonic PBS buffer (0.1&#160;M, pH 7.4). Following cell lysis by ultrasonication, the test mixture was prepared according to the reagent kit instructions, and the absorbance was measured at 405&#160;nm via an enzyme-linked immunosorbent assay.</p></sec><sec id="Sec16"><title>Assay of the apoptosis rate</title><p id="Par19">Well-cultured HT22 cells were inoculated in a six-well plate. When the cell density reached approximately 70&#8722;80%, different treatments were carried out for 24&#160;h: a control group, a NaAsO<sub>2</sub> group (12.5 &#181;M), and a NaAsO<sub>2</sub>&#8201;+&#8201;<italic toggle="yes">S. divaricata</italic> group (12.5 &#181;M&#8201;+&#8201;400&#160;&#181;g/mL). After centrifugation at 1200&#160;rpm for 5&#160;min, each well was washed with 1 mL of PBS to remove residual media. The supernatant was discarded, followed by the addition of 50 &#181;L of bin-containing buffer and 2.5 &#181;L of FITC; this mixture was incubated in the dark for 5&#160;min at room temperature before 5 &#181;L of PI and another 200 &#181;L of PBS were added. Each experiment was repeated three times using different batches of cells.</p></sec><sec id="Sec17"><title>Cellular thermal shift assay (CETSA)</title><p id="Par20">HT22 cells were cultured in 10-cm culture dishes for 24&#160;h and then centrifuged at 12,000&#160;rpm for 5&#160;min at 37&#160;&#176;C. The cells were subsequently resuspended in 1 mL of PBS containing 20 mM Tris-HCl, 100 mM NaCl, 5 mM EDTA, 2 mM phenylmethylsulfonyl fluoride (PMSF), 10 ng/mL leupeptin, and 10&#160;&#181;g/mL aprotinin. Three freeze&#8211;thaw cycles were performed on the cells. The cells were exposed to liquid nitrogen for 3&#160;min each cycle and then heated at 25&#160;&#176;C for 3&#160;min. After centrifugation at 12,000&#160;rpm at 4&#160;&#176;C for half an hour, the supernatants from each group were collected. For the <italic toggle="yes">S. divaricata</italic>-treated groups, <italic toggle="yes">S. divaricata</italic> at 400&#160;&#181;g/mL and NaAsO<sub>2</sub> at 12.5 &#181;M were coadministered for 24&#160;h. For the control groups, NaAsO<sub>2</sub> (12.5 &#181;M) was added for 24&#160;h. All the groups were heated at 25&#160;&#176;C for an hour. The pairs in the control and treatment groups were subsequently heated for 3&#160;min at 46, 49, 52, 55, 58, and 61&#160;&#176;C. Finally, the samples were analyzed by Western blotting.</p></sec><sec id="Sec18"><title>Western blot assay</title><p id="Par21">After total protein was extracted from the cells via the BCA quantitative method, the initial electrophoresis step was performed at 80&#160;V for 30&#160;min, followed by a transition to 120&#160;V for 90&#160;min; the proteins were subsequently transferred to the membrane at 300&#160;mA for 120&#160;min. After the samples were blocked with 5% skim milk powder for 120&#160;min, they were incubated with the primary antibody overnight on a shaking table, followed by incubation with the secondary antibody for 2&#160;h at room temperature, after which electrochemiluminescence was carried out.</p></sec><sec id="Sec19"><title>RT-qPCR analysis</title><p id="Par22">Real-time quantitative PCR was used to assess total RNA levels after culture medium removal whereupon 1 mL of TRIzol lysis solution was introduced per well&#8212;the mixture was thoroughly mixed and then allowed to stand for 5&#160;min on ice prior to the addition of 0.2 mL of chloroform, which necessitated thorough mixing again before the mixture was briefly resuspended and then centrifuged for 15&#160;min at 4&#160;&#176;C and 12,000&#160;rpm. The top aqueous phase was transferred to a new tube, incubated with an equal volume of isopropanol on ice for 15&#160;min, and centrifuged at 4&#160;&#176;C and 12,000&#160;rpm to promote precipitation. The resulting supernatant was discarded, 1 mL of 70% ethanol was added, and the mixture was mixed well, with similar centrifugation steps. The mixture was rolled over filter paper until the ethanol on the wall of the EP tube was air-dried, allowing subsequent dissolution within 20 &#181;L of DEPC-treated water, which was subsequently stored frozen (&#8722; 80&#160;&#176;C). Micro-UV spectrophotometry was used to measure the RNA concentration. The reverse transcription reaction system adhered strictly as outlined within the Reagent Kit protocols, yielding a total reaction volume of 20 &#181;L aimed toward first-strand cDNA synthesis, whereas real-time PCR amplification systems comprised 10 &#181;L configured precisely as instructed therein with the respective reagent boxes employed.</p></sec></sec><sec id="Sec20"><title>Statistical analysis</title><p id="Par23">Statistical analysis was performed using GraphPad Prism 8.0 (GraphPad Software, San Diego, CA) and SPSS Statistics 19.0 (IBM Corp., Armonk, NY). All values were expressed as mean&#8201;&#177;&#8201;standard deviation. Student&#8217;s t-tests were performed to compare the means between two groups, whereas one-way ANOVA was used to compare the mean of three or more groups. Significance threshold was <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05.</p></sec></sec><sec id="Sec21"><title>Results</title><sec id="Sec22"><title>Obtaining <italic toggle="yes">Saposhnikovia divaricata</italic> targets</title><p id="Par24">According to the TCMSP database results, 18 active ingredients for <italic toggle="yes">S. divaricata</italic> were obtained, as shown in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>, including (2R, 3R)-3-(4-hydroxy-3-methoxy-phenyl) -5-methoxy-2-methyl-2,3-dihydropyrano [5,6-h][1,4] benzodioxin-9-one (chloramphenicol A), 11-hydroxysec-o-beta-d-glucosylhamaudol_qt, anomalin, divaricatacid, divaricatol, Ammidin, ledebouriellol, phelloptorin, 5-O-Methylvisamminol, Phellopterin, sitosterol, wogonin, betasitosterol, Mandenol, isoimperatorin, Prangenidin, methyl icosa-11,14-dienoate, and Decursin. Based on databases such as PubChem and SwissTarget Prediction, we obtained 209 <italic toggle="yes">S. divaricata</italic> targets. Through integration and matching, 137 duplicate targets were removed, and 72 target areas were ultimately identified.</p><p id="Par25">
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Active ingredients of traditional Chinese medicine <italic toggle="yes">S. divaricata</italic>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Mol ID</th><th align="left" colspan="1" rowspan="1">Molecule name</th><th align="left" colspan="1" rowspan="1">Number</th><th align="left" colspan="1" rowspan="1">OB (%)</th><th align="left" colspan="1" rowspan="1">DL</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OL000011">OL000011</ext-link></td><td align="left" colspan="1" rowspan="1">(2R,3R)-3-(4-hydroxy-3-methoxy-phenyl)-5-methoxy-2-methylol-2,3-dihydropyrano[5,6-h][1,4]benzodioxin-9-one</td><td align="left" colspan="1" rowspan="1">D1</td><td char="." align="char" colspan="1" rowspan="1">68.83</td><td char="." align="char" colspan="1" rowspan="1">0.6</td></tr><tr><td align="left" colspan="1" rowspan="1">MOL011730</td><td align="left" colspan="1" rowspan="1">11-Hydroxy-sec-o-beta-d-glucosylhamaudol_qt</td><td align="left" colspan="1" rowspan="1">D2</td><td char="." align="char" colspan="1" rowspan="1">50.24</td><td char="." align="char" colspan="1" rowspan="1">0.27</td></tr><tr><td align="left" colspan="1" rowspan="1">MOL011732</td><td align="left" colspan="1" rowspan="1">Anomalin</td><td align="left" colspan="1" rowspan="1">D3</td><td char="." align="char" colspan="1" rowspan="1">59.65</td><td char="." align="char" colspan="1" rowspan="1">0.66</td></tr><tr><td align="left" colspan="1" rowspan="1">MOL011737</td><td align="left" colspan="1" rowspan="1">Divaricatacid</td><td align="left" colspan="1" rowspan="1">D4</td><td char="." align="char" colspan="1" rowspan="1">87.00</td><td char="." align="char" colspan="1" rowspan="1">0.32</td></tr><tr><td align="left" colspan="1" rowspan="1">MOL011740</td><td align="left" colspan="1" rowspan="1">Divaricatol</td><td align="left" colspan="1" rowspan="1">D5</td><td char="." align="char" colspan="1" rowspan="1">31.65</td><td char="." align="char" colspan="1" rowspan="1">0.38</td></tr><tr><td align="left" colspan="1" rowspan="1">MOL001941</td><td align="left" colspan="1" rowspan="1">Ammidin</td><td align="left" colspan="1" rowspan="1">D6</td><td char="." align="char" colspan="1" rowspan="1">34.55</td><td char="." align="char" colspan="1" rowspan="1">0.22</td></tr><tr><td align="left" colspan="1" rowspan="1">MOL011747</td><td align="left" colspan="1" rowspan="1">Ledebouriellol</td><td align="left" colspan="1" rowspan="1">D7</td><td char="." align="char" colspan="1" rowspan="1">32.05</td><td char="." align="char" colspan="1" rowspan="1">0.51</td></tr><tr><td align="left" colspan="1" rowspan="1">MOL011749</td><td align="left" colspan="1" rowspan="1">Phelloptorin</td><td align="left" colspan="1" rowspan="1">D8</td><td char="." align="char" colspan="1" rowspan="1">43.39</td><td char="." align="char" colspan="1" rowspan="1">0.28</td></tr><tr><td align="left" colspan="1" rowspan="1">MOL011753</td><td align="left" colspan="1" rowspan="1">5-O-Methylvisamminol</td><td align="left" colspan="1" rowspan="1">D9</td><td char="." align="char" colspan="1" rowspan="1">37.99</td><td char="." align="char" colspan="1" rowspan="1">0.25</td></tr><tr><td align="left" colspan="1" rowspan="1">MOL002644</td><td align="left" colspan="1" rowspan="1">Phellopterin</td><td align="left" colspan="1" rowspan="1">D10</td><td char="." align="char" colspan="1" rowspan="1">40.19</td><td char="." align="char" colspan="1" rowspan="1">0.28</td></tr><tr><td align="left" colspan="1" rowspan="1">MOL000359</td><td align="left" colspan="1" rowspan="1">Sitosterol</td><td align="left" colspan="1" rowspan="1">D11</td><td char="." align="char" colspan="1" rowspan="1">36.91</td><td char="." align="char" colspan="1" rowspan="1">0.75</td></tr><tr><td align="left" colspan="1" rowspan="1">MOL000173</td><td align="left" colspan="1" rowspan="1">Wogonin</td><td align="left" colspan="1" rowspan="1">D12</td><td char="." align="char" colspan="1" rowspan="1">30.68</td><td char="." align="char" colspan="1" rowspan="1">0.23</td></tr><tr><td align="left" colspan="1" rowspan="1">MOL000358</td><td align="left" colspan="1" rowspan="1">Beta-sitosterol</td><td align="left" colspan="1" rowspan="1">D13</td><td char="." align="char" colspan="1" rowspan="1">36.91</td><td char="." align="char" colspan="1" rowspan="1">0.75</td></tr><tr><td align="left" colspan="1" rowspan="1">MOL001494</td><td align="left" colspan="1" rowspan="1">Mandenol</td><td align="left" colspan="1" rowspan="1">D14</td><td char="." align="char" colspan="1" rowspan="1">42.00</td><td char="." align="char" colspan="1" rowspan="1">0.19</td></tr><tr><td align="left" colspan="1" rowspan="1">MOL001942</td><td align="left" colspan="1" rowspan="1">Isoimperatorin</td><td align="left" colspan="1" rowspan="1">D15</td><td char="." align="char" colspan="1" rowspan="1">45.46</td><td char="." align="char" colspan="1" rowspan="1">0.23</td></tr><tr><td align="left" colspan="1" rowspan="1">MOL003588</td><td align="left" colspan="1" rowspan="1">Prangenidin</td><td align="left" colspan="1" rowspan="1">D16</td><td char="." align="char" colspan="1" rowspan="1">36.31</td><td char="." align="char" colspan="1" rowspan="1">0.22</td></tr><tr><td align="left" colspan="1" rowspan="1">MOL007514</td><td align="left" colspan="1" rowspan="1">Methyl icosa-11,14-dienoate</td><td align="left" colspan="1" rowspan="1">D17</td><td char="." align="char" colspan="1" rowspan="1">39.67</td><td char="." align="char" colspan="1" rowspan="1">0.23</td></tr><tr><td align="left" colspan="1" rowspan="1">MOL013077</td><td align="left" colspan="1" rowspan="1">Decursin</td><td align="left" colspan="1" rowspan="1">D18</td><td char="." align="char" colspan="1" rowspan="1">39.27</td><td char="." align="char" colspan="1" rowspan="1">0.38</td></tr></tbody></table></table-wrap>
</p></sec><sec id="Sec23"><title>Construction of a network of effective ingredients for <italic toggle="yes">S. divaricata</italic>, targets, and arsenic poisoning</title><p id="Par26">Through the GeneCards database, we obtained a total of 9717 genes related to nerve damage, with 2224 genes related to arsenic poisoning. By crossing 72 effective ingredient targets for <italic toggle="yes">S. divaricata</italic> with 9717 genes related to nerve damage and 2224 genes related to arsenic poisoning, 45 effective ingredient&#8210;disease interaction targets were obtained, as shown in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>A. A STRING database was used to perform protein interaction analysis on 45 active ingredient targets, and Cytoscape 3.6.0 was used to perform &#8220;active ingredient&#8210;disease target&#8221; network analysis. The results are shown in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>B, where AKT1, CASP3, IL6, and TP53 were key ingredient targets.</p><p id="Par27">
<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Network pharmacology analysis. (<bold>A</bold>) Venn diagram. (<bold>B</bold>) Interactive PPI network for disease and drug targets. The deeper and larger the node indicated stronger protein-protein connectivity. The top four networks targets analyzed by PPI were AKT1, CASP3, IL6, and TP53, respectively. (<bold>C</bold>) CC cellular component, (<bold>D</bold>) BP biological process, (<bold>E</bold>) MF molecular function. (<bold>F</bold>) KEGG pathway enrichment analysis. (<bold>G</bold>) The construction of the protein interaction network diagram on the PI3K/AKT pathway with the AKT1 node the largest and darkest in color. (<bold>H</bold>) Molecular docking. The main target, AKT1, of the PI3K/AKT signaling pathway was related to the active components such as 5-Methylvisaminol, andromalin, &#946;-Sitosterol, Decursin, isoImperatorin, ledebourielle, Phelloperin, Pragenidin and wogonin.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e863" position="float" orientation="portrait" xlink:href="41598_2025_4735_Fig1_HTML.jpg"/></fig>
</p></sec><sec id="Sec24"><title>GO and KEGG enrichment analysis</title><p id="Par28">The 45 effective components of <italic toggle="yes">S. divaricata</italic> and disease interaction targets involved biological processes (BP), cellular components (CC), and molecular functions (MF), with the top 10 enriched, as shown in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>C&#8211;E. Its mechanism of action includes action on lipopolysaccharides (LPS) and reactive oxygen species (ROS). Figure&#160;<xref rid="Fig1" ref-type="fig">1</xref>F shows the top 10 pathways with the highest enrichment of 45 active ingredient&#8210;disease interaction targets.</p></sec><sec id="Sec25"><title>Construction of a protein interaction network diagram of the PI3K/AKT pathway</title><p id="Par29">Because AKT1 is a key component target for arsenic-induced nerve damage and ranks among the top 10 enriched pathways in the PI3K/AKT pathway, the relevant genes in this pathway were analyzed for their protein&#8210;protein interactions through STRING analysis and imported into Cytoscape 3.7.2 to construct an &#8220;active ingredient&#8210;disease target&#8221; network. The results are shown in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>G, where AKT1 was the most important key target.</p></sec><sec id="Sec26"><title>Molecular docking</title><p id="Par30">Using Discovery Studio 2016, the key target AKT1 in the PI3K/AKT signaling pathway was identified, which has binding sites with the active ingredients 5-O-Methylvisamminol, anomalin, beta-sitosterol, Decursin, isoimperatorin, ledebouriellol, Phellopterin, Prangenidin and wogonin of <italic toggle="yes">S. divaricata</italic>, and their binding energy values are shown in Table&#160;<xref rid="Tab2" ref-type="table">2</xref>. Therefore, AKT1 had good binding activity, and the specific binding mode is shown in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>H.</p><p id="Par31">
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>The binding energy value of AKT1 and the active ingredients of <italic toggle="yes">S. divaricata</italic>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Target</th><th align="left" colspan="1" rowspan="1">Active compounds</th><th align="left" colspan="1" rowspan="1">Affinity (kcal/mol)</th><th align="left" colspan="1" rowspan="1">Targeting residues</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">AKT1</td><td align="left" colspan="1" rowspan="1">5-O-Methylvisamminol</td><td char="." align="char" colspan="1" rowspan="1">&#8722; 5.9</td><td align="left" colspan="1" rowspan="1">ARG-15, THR-87, LYS-20</td></tr><tr><td align="left" colspan="1" rowspan="1">AKT1</td><td align="left" colspan="1" rowspan="1">Anomalin</td><td char="." align="char" colspan="1" rowspan="1">&#8722; 6.1</td><td align="left" colspan="1" rowspan="1">THR-21, LEU-52</td></tr><tr><td align="left" colspan="1" rowspan="1">AKT1</td><td align="left" colspan="1" rowspan="1">Beta-sitosterol</td><td char="." align="char" colspan="1" rowspan="1">&#8722; 6.6</td><td align="left" colspan="1" rowspan="1">ARG-23</td></tr><tr><td align="left" colspan="1" rowspan="1">AKT1</td><td align="left" colspan="1" rowspan="1">Decursin</td><td char="." align="char" colspan="1" rowspan="1">&#8722; 6.5</td><td align="left" colspan="1" rowspan="1">ILE-19T, YR-18, GLU-17</td></tr><tr><td align="left" colspan="1" rowspan="1">AKT1</td><td align="left" colspan="1" rowspan="1">Isoimperatorin</td><td char="." align="char" colspan="1" rowspan="1">&#8722; 5.9</td><td align="left" colspan="1" rowspan="1">LYS-14</td></tr><tr><td align="left" colspan="1" rowspan="1">AKT1</td><td align="left" colspan="1" rowspan="1">Ledebouriellol</td><td char="." align="char" colspan="1" rowspan="1">&#8722; 6.7</td><td align="left" colspan="1" rowspan="1">ARG-86, ASN-53 TRY-18, GLU-17</td></tr><tr><td align="left" colspan="1" rowspan="1">AKT1</td><td align="left" colspan="1" rowspan="1">Phellopterin</td><td char="." align="char" colspan="1" rowspan="1">&#8722; 6.1</td><td align="left" colspan="1" rowspan="1">ILE-19, LYS-14</td></tr><tr><td align="left" colspan="1" rowspan="1">AKT1</td><td align="left" colspan="1" rowspan="1">Prangenidin</td><td char="." align="char" colspan="1" rowspan="1">&#8722; 6.7</td><td align="left" colspan="1" rowspan="1">ARG-25, ASN-53, LEU-52</td></tr><tr><td align="left" colspan="1" rowspan="1">AKT1</td><td align="left" colspan="1" rowspan="1">Wogonin</td><td char="." align="char" colspan="1" rowspan="1">&#8722; 7.5</td><td align="left" colspan="1" rowspan="1">ARG-23, ARG-25, ASN-53, THR-21, ILE-19</td></tr></tbody></table></table-wrap>
</p></sec><sec id="Sec27"><title><italic toggle="yes">Saposhnikovia divaricata</italic> reversed NaAsO<sub>2</sub>-induced changes in morphology and cell viability</title><p id="Par32">HT22 cells were treated with different concentrations of NaAsO<sub>2</sub> (0, 3.125, 6.25, and 12.5 &#181;M) for 24&#160;h. CCK8 analysis revealed that NaAsO<sub>2</sub> could reduce HT22 cell viability to varying degrees (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01) and inhibit cell proliferation. In addition, 12.5 &#181;M NaAsO<sub>2</sub> was the optimal condition for the intervention of HT22 cells for 24&#160;h, and <italic toggle="yes">S. divaricata</italic> resulted in the most significant reversal of NaAsO<sub>2</sub> damage to HT22 cells at 400&#160;&#181;g/mL, as shown in Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>A. After 24&#160;h of NaAsO<sub>2</sub> and <italic toggle="yes">S. divaricata</italic> treatment, we observed morphological changes in HT22 cells via optical microscopy and found that, compared with the control group, the NaAsO<sub>2</sub> treatment group presented a decreased number of HT22 cells, an increased number of dead cells, and increased transparency. The cell morphology was circular, and the neural processes were significantly shortened. Compared with that in the NaAsO<sub>2</sub> treatment group, the morphology of the cells in the NaAsO<sub>2</sub>&#8201;+&#8201;<italic toggle="yes">S. divaricata</italic> treatment group was significantly improved, indicating that <italic toggle="yes">S. divaricata</italic> had a certain protective effect on NaAsO<sub>2</sub>-induced morphological damage in HT22 cells, as shown in Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>B.</p><p id="Par33">
<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Effects of <italic toggle="yes">S. divaricata</italic> on the morphological changes, viability, oxidative stress, apoptosis of HT22 cells induced by NaAsO<sub>2</sub>. (<bold>A</bold>) Cell viability of HT22 cells in each group. (<bold>B</bold>) Cell morphology in each group under the microscope. (<bold>C</bold>) ROS content was assessed by Flow cytometry in each group. (<bold>D</bold>) ROS content statistical chart (<bold>E</bold>) GSH content was assessed by ELISA in each group. (<bold>F</bold>) Apoptosis rates of HT22 cells were assessed by Flow cytometry in each group. (<bold>G</bold>) Apoptosis rates statistical chart. (<bold>H</bold>) The relative mRNA levels of Bcl2, Bax, Caspase8, Caspase3, and Cleaved-caspase3 in HT22 cells were assessed by RT-qPCR. (<bold>I</bold>) The protein expressions of cleaved Bcl2, Bax, Caspase8, Caspase3 and Cleaved-caspase3 were assessed by Western blot. (<bold>J</bold>) Statistical analysis of the expression intensity of Bcl2, Bax, Caspase8, Caspase3 and Cleaved-caspase3 in HT22 cells. GAPDH served as internal reference. *<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05, **<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01 vs. control group; <sup>^</sup><italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05, <sup>^^</sup><italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01 vs. 3.125 group; <sup>$</sup><italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05, <sup>$$</sup><italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01 vs. 6.25 group, <sup>#</sup><italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05, <sup>##</sup><italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01 vs. NaAsO<sub>2</sub> (12.5) group, <sup>&amp;</sup><italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05 vs. 12.5&#8201;+&#8201;300 group. The data was displayed as mean&#8201;&#177;&#8201;standard deviation, <italic toggle="yes">n</italic>&#8201;=&#8201;3.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1144" position="float" orientation="portrait" xlink:href="41598_2025_4735_Fig2_HTML.jpg"/></fig>
</p></sec><sec id="Sec28"><title><italic toggle="yes">Saposhnikovia divaricata</italic> reversed NaAsO<sub>2</sub>-induced oxidative stress</title><p id="Par34">To investigate the protective effects of <italic toggle="yes">S. divaricata</italic> on NaAsO<sub>2</sub>-induced HT22 cell toxicity, we detected the levels of ROS and GSH synthesis in HT22 cells via flow cytometry and ELISA. The following groups of cells were established: the control group, NaAsO<sub>2</sub> (12.5 &#181;M) group, and NaAsO<sub>2</sub>&#8201;+&#8201;<italic toggle="yes">S. divaricata</italic> (12.5 &#181;M&#8201;+&#8201;400&#160;&#181;g/mL) group. Compared with that in the control group, the ROS content in the NaAsO<sub>2</sub> group increased from 100&#8201;&#177;&#8201;55.97% to 421.99&#8201;&#177;&#8201;75.12% (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01). Compared with that in the NaAsO<sub>2</sub> group, the ROS content in the NaAsO<sub>2</sub>&#8201;+&#8201;<italic toggle="yes">S. divaricata</italic> group decreased from 421.99&#8201;&#177;&#8201;75.12% to 166.46&#8201;&#177;&#8201;89.49% (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01), as shown in Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>C,D. Compared with that in the control group, the GSH synthesis in the NaAsO<sub>2</sub> treatment group greatly decreased (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01), whereas compared with that in the NaAsO<sub>2</sub> treatment group, GSH synthesis significantly increased in the NaAsO<sub>2</sub>&#8201;+&#8201;<italic toggle="yes">S. divaricata</italic> treatment group (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01), as shown in Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>E, indicating that <italic toggle="yes">S. divaricata</italic> could reverse NaAsO<sub>2</sub>-induced oxidative stress in HT22 cells.</p></sec><sec id="Sec29"><title><italic toggle="yes">Saposhnikovia divaricata</italic> downregulated NaAsO<sub>2</sub>-induced apoptosis</title><p id="Par35">In this study, we explored the effects of <italic toggle="yes">S. divaricata</italic> on NaAsO<sub>2</sub>-induced apoptosis in HT22 cells. Compared with that of the control group, the apoptosis rate of the NaAsO<sub>2</sub> group significantly increased from 1.83&#8201;&#177;&#8201;0.41% to 18.65&#8201;&#177;&#8201;1.29% (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01); compared with that of the NaAsO<sub>2</sub> group, the apoptosis rate of the NaAsO<sub>2</sub>&#8201;+&#8201;<italic toggle="yes">S. divaricata</italic> group decreased from 18.65&#8201;&#177;&#8201;1.29% to 7.53&#8201;&#177;&#8201;1.03% (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01), as shown in Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>F,G. Compared with those in the control group, the protein expression and mRNA levels of Bcl2 in the NaAsO<sub>2</sub> group were decreased, whereas the protein expression and mRNA levels of Bax, Caspase8, Caspase3, and Cleaved-caspase3 were increased (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01). Compared with those in the NaAsO<sub>2</sub> group, the protein expression and mRNA levels of Bax, Caspase8, Caspase3 and Cleaved-caspase3 in the NaAsO<sub>2</sub>&#8201;+&#8201;<italic toggle="yes">S. divaricata</italic> group were increased, whereas the protein expression and mRNA levels of Bax, Caspase8, Caspase3, and Cleaved-caspase3 were decreased (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01), as shown in Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>H&#8211;J.</p></sec><sec id="Sec30"><title>The PI3K/AKT pathway May be a key target for <italic toggle="yes">Saposhnikovia divaricata</italic></title><p id="Par36">To identify drug targets, we analyzed the binding model between the active ingredients of <italic toggle="yes">S. divaricata</italic> and AKT1 protein via molecular docking technology, as shown in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>H. We found that AKT1 could bind to multiple active ingredients of <italic toggle="yes">S. divaricata</italic>, resulting in a stable binding conformation. The correlation between the <italic toggle="yes">S. divaricata</italic> and PI3K/AKT ratio was tested via CETSA experiments. Compared with NaAsO<sub>2</sub> treatment, <italic toggle="yes">S. divaricata</italic> treatment increased the stability of PI3K and AKT (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>A,B). These results indicate that the PI3K/AKT pathway may be a key target for <italic toggle="yes">S. divaricata</italic>.</p><p id="Par37">
<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><p>Identification of PI3K/AKT as the key target for <italic toggle="yes">S. divaricata</italic>. (<bold>A</bold>) The interaction of <italic toggle="yes">S. divaricata</italic> with PI3K and AKT was assessed by cell thermal displacement measurement in HT22 cells. (<bold>B</bold>) Quantification of the relative intensity of the PI3K and AKT proteins versus increased temperature. GAPDH served as an internal reference. (<bold>C</bold>) The protein expressions of p-PI3K, PI3K, p-AKT, AKT and Nrf2 were assessed by Western Blot. (<bold>D</bold>) Statistical analysis of the ratio<italic toggle="yes">s</italic> of p-PI3K/PI3K, p-AKT/AKT and the expression intensity of Nrf2 in HT22 cells. GAPDH served as an internal reference. *<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05, **<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01 vs. control group, <sup>#</sup><italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05, <sup>##</sup><italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01 vs. NaAsO<sub>2</sub> group. The control group was used for comparison. The data was displayed as mean&#8201;&#177;&#8201;standard deviation, <italic toggle="yes">n</italic>&#8201;=&#8201;3.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1345" position="float" orientation="portrait" xlink:href="41598_2025_4735_Fig3_HTML.jpg"/></fig>
</p></sec><sec id="Sec31"><title><italic toggle="yes">Saposhnikovia divaricata</italic> activated the PI3K/AKT pathway inhibited by NaAsO<sub>2</sub></title><p id="Par38">Finally, to confirm that PI3K/AKT is a target for <italic toggle="yes">S. divaricata</italic>, we detected the expression of PI3K/AKT pathway proteins and the key downstream signaling molecule Nrf2. Compared with those in the control group, the ratios of p-PI3K/PI3K and p-AKT/AKT and the protein expression of Nrf2 in the NaAsO<sub>2</sub> group were lower (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01). Compared with the NaAsO<sub>2</sub> group, the NaAsO<sub>2</sub>&#8201;+&#8201;<italic toggle="yes">S. divaricata</italic> group increased the ratios of p-PI3K/PI3K, p-AKT/AKT, and Nrf2 protein expression (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01), as shown in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>C,D.</p></sec></sec><sec id="Sec32"><title>Discussion</title><p id="Par39"><italic toggle="yes">Saposhnikovia divaricata</italic>, with a spicy, sweet, slightly warm taste, belongs to the bladder, spleen, and liver channels<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. As a traditional Chinese medicinal material, <italic toggle="yes">S. divaricata</italic> is considered a top-grade medicinal herb in the monograph of Shennong Materia Medica<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR23">23</xref></sup>. Its active ingredients include mainly chromogenic ketones, polysaccharides, volatile oils, and coumarins, which can eliminate excessive arsenic in the human body and exert strong detoxification effects (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>)<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. Through network pharmacology exploration, a comprehensive dataset was compiled, identifying 78 <italic toggle="yes">S. divaricata</italic> targets, 9717 nerve injury targets, and 2224 arsenic poisoning targets, with an additional 45 putative targets identified through intersection analysis (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>A). GO annotations and KEGG pathway analyses of these protein targets revealed significant enrichment in apoptotic processes (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>C&#8211;F). Mochizuki et al. further corroborated that NaAsO<sub>2</sub> induces neurotoxicity through apoptotic mechanisms and affects intracellular signaling pathways<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. Guided by the results of the enrichment analysis of the top 10 pivotal targets and pathways, the PI3K/AKT signaling pathway was selected as a critical regulatory axis for subsequent investigations<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. By utilizing the degree algorithm for topological profiling of the &#8220;potential targets&#8221;, the most pivotal target, AKT1, was identified (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>G), followed by molecular docking exercises with the efficacious <italic toggle="yes">S. divaricata</italic> target (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>H).</p><p id="Par40">Arsenic-containing compounds, such as NaAsO<sub>2</sub> and As<sub>2</sub>O<sub>3</sub>, can disrupt normal neural function by interfering with neurotransmitter synthesis and nerve signal transduction<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. Our assessment revealed a gradual decline in viability and cell number along with shortened protrusions and a rounded morphology induced by increasing concentrations of NaAsO<sub>2</sub> under the microscope. However, <italic toggle="yes">S. divaricata</italic> ameliorated these morphological changes, resulting in a substantial increase in cell viability (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>A). Liu et al. reported that As<sub>2</sub>O<sub>3</sub> could induce oxidative stress, causing oxidative damage to cell membranes and organelles while accelerating neuronal aging and death<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. We also observed that NaAsO<sub>2</sub> significantly elevated the ROS content within the cells while concurrently decreasing the GSH content, whereas <italic toggle="yes">S. divaricata</italic> exhibited neuroprotective effects by decreasing the level of ROS and increasing the GSH content (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>C&#8211;E). Apoptosis is tightly regulated by various genes, including those in the Bcl2 and Caspase families<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. Bax and Bcl2 are prominent members of the B-cell lymphoma/leukemia-2 (Bcl2) family, and they play opposite roles in NaAsO<sub>2</sub>-induced apoptosis<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>. Bax is typically regarded as an apoptosis-promoting protein that increases mitochondrial membrane permeability, leading to cytochrome C release along with other proapoptotic factors that initiate apoptotic pathways<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup>. Conversely, Bcl2 functions primarily as an antiapoptotic protein, protecting mitochondrial integrity and thereby inhibiting apoptosis<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. Cleaved-caspase3, Caspase3 and Caspase8 are key regulatory factors in the process of apoptosis<sup><xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup>. Caspases 3 and 8 are pivotal for executing and initiating apoptosis, respectively. Caspase8 acts as an initiating protease involved in external apoptotic signaling cascades triggered by receptor-mediated stimuli, whereas activated Caspase3 orchestrates subsequent apoptotic events, including nuclear DNA degradation alongside alterations in cell morphology, culminating in apoptosis itself<sup><xref ref-type="bibr" rid="CR37">37</xref>&#8211;<xref ref-type="bibr" rid="CR40">40</xref></sup>. Flow cytometry analysis indicated a marked increase in the apoptosis rate in HT22 cells subjected to NaAsO<sub>2</sub> treatment, which was notably reduced by <italic toggle="yes">S. divaricata</italic> intervention (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>F,G). Western blot and RT-qPCR analysis further confirmed that <italic toggle="yes">S. divaricata</italic> decreased the levels of the proapoptotic protein and mRNA of Bax, Caspase8, Caspase3, and Cleaved-caspase3, but increased the level of the antiapoptotic protein Bcl2 in NaAsO&#8322;-treated HT22 cells (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>H&#8211;J). Therefore, these data confirmed our network pharmacological prediction that <italic toggle="yes">S. divaricata</italic> effectively alleviates NaA<sub>S</sub>O<sub>2</sub>-induced neuronal apoptosis and related oxidative stress.</p><p id="Par41">Based on the findings from our network pharmacological analysis, we further investigated the roles played by the PI3K/AKT signaling pathway in HT22 cells to elucidate the molecular mechanisms underlying the ability of the <italic toggle="yes">S. divaricata</italic> to antagonize arsenic neurotoxicity. Studies have shown that the PI3K/AKT pathway plays an important role in arsenic induced neuronal apoptosis<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. This pathway comprises three key family members: PI3K, AKT and Nrf2. Stress-activated PI3K and AKT are pivotal in maintaining a balance between cell survival and death<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. Through CETSA experiments, we confirmed that the PI3K/AKT pathway represents a potential target for <italic toggle="yes">S. divaricata</italic> treatmen<italic toggle="yes">t</italic>. In addition, the upregulation of the p-PI3K/PI3K and p-AKT/AKT ratios and Nrf2 protein expression were also observed in the <italic toggle="yes">S. divaricata</italic> group; we hypothesized that this may be due to the interaction between <italic toggle="yes">S. divaricata</italic>, NaAsO<sub>2</sub> and the PI3K/AKT pathway, leading to increased activity of the PI3K/AKT pathway. Acting as both the key downstream regulator in the PI3K/AKT pathway and the oxidative stress transcription factor, Nrf2 may inhibit cell apoptosis by regulating the expressions of Bcl2 and Bax. Our results indicated that NaAsO<sub>2</sub> could inhibit the PI3K/AKT pathway, downregulating Nrf2 levels in HT22 cells. Conversely, <italic toggle="yes">S. divaricata</italic> activated NaAsO<sub>2</sub>-inhibited signaling and antagonized the NaAsO<sub>2</sub>-induced downregulation of Nrf2 (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>).</p><p id="Par42">Therefore, <italic toggle="yes">S. divaricata</italic> can alleviate NaAsO<sub>2</sub>-induced cellular apoptosis, thereby reducing associated neurotoxic effects by activating the PI3K/AKT signaling pathway. Considering certain limitations within this study, additional in vitro studies are necessary to validate these mechanisms.</p></sec><sec id="Sec33"><title>Conclusion</title><p id="Par43">Network pharmacology revealed that the effects of <italic toggle="yes">S. divaricata</italic> on NaAsO<sub>2</sub>-induced neurotoxicity are intimately associated with apoptosis and the PI3K/AKT pathway. The experimental findings revealed that <italic toggle="yes">S. divaricata</italic> exerted therapeutic effects via antioxidant, anti-inflammatory, and anti-apoptotic activities, which may be related to the activation of the PI3K/AKT pathway. Hence, <italic toggle="yes">S. divaricata</italic> could be employed as a novel therapeutic modality to prevent nerve damage associated with NaAsO<sub>2</sub>.</p></sec><sec id="Sec34" sec-type="supplementary-material"><title>Electronic supplementary material</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41598_2025_4735_MOESM1_ESM.pdf" position="float" orientation="portrait"><caption><p>Supplementary Material 1</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Dan Gu, Xian-Li Chen, Heng-Lin He and Mei Xia contributed equally to this work.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This work was supported by the National Natural Science Foundation of China (NO. 31960188), Guizhou Provincial College Students&#8217; Innovation and Entrepreneurship Training Program Project (NO. S202210660078, S202210660077), Guizhou Provincial Science and Technology Support Project (No. 2021-General 415) and the Department of Education of Guizhou Province (Guizhou Teaching and Technology [2023]015).</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>D.G.: Validation, visualization; D.G., X.-L.C., H.-L.H., M.X.: Writing-original draft, data curation, methodology; J.-G.P., W.Z.: Writing-review and editing, funding acquisition, supervision; D.G., X.-Y.W., Y.-Y.C., W.-R.K.: Formal analysis; G.-H.H., J.-Y.H., X.-L.Z.: Formal analysis, data curation. B.-F.S., X.-H.L.: Funding acquisition. S.-H.L.: Identification of voucher specimens.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The data underlying this article will be shared on reasonable request, with the corresponding author.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par49">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabelin</surname><given-names>CB</given-names></name><etal/></person-group><article-title>Arsenic, selenium, boron, lead, cadmium, copper, and zinc in naturally contaminated rocks: A review of their sources, modes of enrichment, mechanisms of release, and mitigation strategies</article-title><source>Sci. Total Environ.</source><year>2018</year><volume>645</volume><fpage>1522</fpage><lpage>1553</lpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2018.07.103</pub-id><pub-id pub-id-type="pmid">30248873</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Tabelin, C. B. et al. Arsenic, selenium, boron, lead, cadmium, copper, and zinc in naturally contaminated rocks: A review of their sources, modes of enrichment, mechanisms of release, and mitigation strategies. <italic toggle="yes">Sci. Total Environ.</italic><bold>645</bold>, 1522&#8211;1553. 10.1016/j.scitotenv.2018.07.103 (2018).<pub-id pub-id-type="pmid">30248873</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.scitotenv.2018.07.103</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tyler</surname><given-names>CR</given-names></name><name name-style="western"><surname>Allan</surname><given-names>AM</given-names></name></person-group><article-title>The effects of arsenic exposure on neurological and cognitive dysfunction in human and rodent studies: A review</article-title><source>Curr. Environ. Health Rep.</source><year>2014</year><volume>1</volume><issue>2</issue><fpage>132</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1007/s40572-014-0012-1</pub-id><pub-id pub-id-type="pmid">24860722</pub-id><pub-id pub-id-type="pmcid">PMC4026128</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Tyler, C. R. &amp; Allan, A. M. The effects of arsenic exposure on neurological and cognitive dysfunction in human and rodent studies: A review. <italic toggle="yes">Curr. Environ. Health Rep.</italic><bold>1</bold> (2), 132&#8211;147. 10.1007/s40572-014-0012-1 (2014).<pub-id pub-id-type="pmid">24860722</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40572-014-0012-1</pub-id><pub-id pub-id-type="pmcid">PMC4026128</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamauchi</surname><given-names>H</given-names></name><name name-style="western"><surname>Hitomi</surname><given-names>T</given-names></name><name name-style="western"><surname>Takata</surname><given-names>A</given-names></name></person-group><article-title>Evaluation of arsenic metabolism and tight junction injury after exposure to arsenite and monomethylarsonous acid using a rat in vitro blood-Brain barrier model</article-title><source>PLoS One</source><year>2023</year><volume>18</volume><issue>11</issue><fpage>e0295154</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0295154</pub-id><pub-id pub-id-type="pmid">38032905</pub-id><pub-id pub-id-type="pmcid">PMC10688625</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Yamauchi, H., Hitomi, T. &amp; Takata, A. Evaluation of arsenic metabolism and tight junction injury after exposure to arsenite and monomethylarsonous acid using a rat in vitro blood-Brain barrier model. <italic toggle="yes">PLoS One</italic>. <bold>18</bold> (11), e0295154. 10.1371/journal.pone.0295154 (2023).<pub-id pub-id-type="pmid">38032905</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0295154</pub-id><pub-id pub-id-type="pmcid">PMC10688625</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chu</surname><given-names>F</given-names></name><etal/></person-group><article-title>Unveiling the LncRNA-miRNA-mRNA regulatory network in arsenic-induced nerve injury in rats through high-throughput sequencing</article-title><source>Toxics</source><year>2023</year><volume>11</volume><issue>12</issue><fpage>953</fpage><pub-id pub-id-type="doi">10.3390/toxics11120953</pub-id><pub-id pub-id-type="pmid">38133354</pub-id><pub-id pub-id-type="pmcid">PMC10747658</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Chu, F. et al. Unveiling the LncRNA-miRNA-mRNA regulatory network in arsenic-induced nerve injury in rats through high-throughput sequencing. <italic toggle="yes">Toxics</italic>. <bold>11</bold> (12), 953. 10.3390/toxics11120953 (2023).<pub-id pub-id-type="pmid">38133354</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/toxics11120953</pub-id><pub-id pub-id-type="pmcid">PMC10747658</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weinmuellner</surname><given-names>R</given-names></name><etal/></person-group><article-title>Long-term exposure of immortalized keratinocytes to arsenic induces EMT, impairs differentiation in organotypic skin models and mimics aspects of human skin derangements</article-title><source>Arch. Toxicol.</source><year>2018</year><volume>92</volume><issue>1</issue><fpage>181</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1007/s00204-017-2034-6</pub-id><pub-id pub-id-type="pmid">28776197</pub-id><pub-id pub-id-type="pmcid">PMC5773649</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Weinmuellner, R. et al. Long-term exposure of immortalized keratinocytes to arsenic induces EMT, impairs differentiation in organotypic skin models and mimics aspects of human skin derangements. <italic toggle="yes">Arch. Toxicol.</italic><bold>92</bold> (1), 181&#8211;194. 10.1007/s00204-017-2034-6 (2018).<pub-id pub-id-type="pmid">28776197</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00204-017-2034-6</pub-id><pub-id pub-id-type="pmcid">PMC5773649</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nurchi</surname><given-names>VM</given-names></name><etal/></person-group><article-title>Arsenic toxicity: molecular targets and therapeutic agents</article-title><source>Biomolecules</source><year>2020</year><volume>10</volume><issue>2</issue><fpage>235</fpage><pub-id pub-id-type="doi">10.3390/biom10020235</pub-id><pub-id pub-id-type="pmid">32033229</pub-id><pub-id pub-id-type="pmcid">PMC7072575</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Nurchi, V. M. et al. Arsenic toxicity: molecular targets and therapeutic agents. <italic toggle="yes">Biomolecules</italic>. <bold>10</bold> (2), 235. 10.3390/biom10020235 (2020).<pub-id pub-id-type="pmid">32033229</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/biom10020235</pub-id><pub-id pub-id-type="pmcid">PMC7072575</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Domingo-Relloso</surname><given-names>A</given-names></name><etal/></person-group><article-title>Arsenic exposure, blood DNA methylation, and cardiovascular disease</article-title><source>C Irc Res.</source><year>2022</year><volume>131</volume><issue>2</issue><fpage>e51</fpage><lpage>e69</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.122.320991</pub-id><pub-id pub-id-type="pmcid">PMC10203287</pub-id><pub-id pub-id-type="pmid">35658476</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Domingo-Relloso, A. et al. Arsenic exposure, blood DNA methylation, and cardiovascular disease. <italic toggle="yes">C Irc Res.</italic><bold>131</bold> (2), e51&#8211;e69. 10.1161/CIRCRESAHA.122.320991 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCRESAHA.122.320991</pub-id><pub-id pub-id-type="pmcid">PMC10203287</pub-id><pub-id pub-id-type="pmid">35658476</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bj&#248;rklund</surname><given-names>G</given-names></name><name name-style="western"><surname>Mutter</surname><given-names>J</given-names></name><name name-style="western"><surname>Aaseth</surname><given-names>J</given-names></name></person-group><article-title>Metal chelators and neurotoxicity: lead, mercury, and arsenic</article-title><source>Arch. Toxicol.</source><year>2017</year><volume>91</volume><issue>12</issue><fpage>3787</fpage><lpage>3797</lpage><pub-id pub-id-type="doi">10.1007/s00204-017-2100-0</pub-id><pub-id pub-id-type="pmid">29063135</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Bj&#248;rklund, G., Mutter, J. &amp; Aaseth, J. Metal chelators and neurotoxicity: lead, mercury, and arsenic. <italic toggle="yes">Arch. Toxicol.</italic><bold>91</bold> (12), 3787&#8211;3797. 10.1007/s00204-017-2100-0 (2017).<pub-id pub-id-type="pmid">29063135</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00204-017-2100-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erdenebileg</surname><given-names>S</given-names></name><etal/></person-group><article-title>Saposhnikovia divaricata root and its major components ameliorate inflammation and altered gut microbial diversity and compositions in DSS-induced colitis</article-title><source>Integr. Med. Res.</source><year>2023</year><volume>12</volume><issue>4</issue><fpage>100998</fpage><pub-id pub-id-type="doi">10.1016/j.imr.2023.100998</pub-id><pub-id pub-id-type="pmid">38024289</pub-id><pub-id pub-id-type="pmcid">PMC10630121</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Erdenebileg, S. et al. Saposhnikovia divaricata root and its major components ameliorate inflammation and altered gut microbial diversity and compositions in DSS-induced colitis. <italic toggle="yes">Integr. Med. Res.</italic><bold>12</bold> (4), 100998. 10.1016/j.imr.2023.100998 (2023).<pub-id pub-id-type="pmid">38024289</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.imr.2023.100998</pub-id><pub-id pub-id-type="pmcid">PMC10630121</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">Huang, Y. N. <italic toggle="yes">Effects of Radix Saposhnikoviae and its Components on ATO Toxicity, and Apoptosis of HL-60/H9c2 Induced ATO[D]</italic> (Chinese Academy of Traditional Chinese Medicine, 2014).</mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">Jiang, C. <italic toggle="yes">Study on the Extraction of the Effective Components and Protective Effect on Experimental Liver Injury with Radix Saposhnikoviae[D]</italic> (Jilin Agricultural University, 2013).</mixed-citation></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cui</surname><given-names>S</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chen</surname><given-names>T</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name></person-group><article-title>A network pharmacology approach to investigate the anti-inflammatory mechanism of effective ingredients from Salvia miltiorrhiza</article-title><source>Int. Immunopharmacol.</source><year>2020</year><volume>81</volume><fpage>106040</fpage><pub-id pub-id-type="doi">10.1016/j.intimp.2019.106040</pub-id><pub-id pub-id-type="pmid">31818704</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Cui, S., Chen, S., Wu, Q., Chen, T. &amp; Li, S. A network pharmacology approach to investigate the anti-inflammatory mechanism of effective ingredients from Salvia miltiorrhiza. <italic toggle="yes">Int. Immunopharmacol.</italic><bold>81</bold>, 106040. 10.1016/j.intimp.2019.106040 (2020).<pub-id pub-id-type="pmid">31818704</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.intimp.2019.106040</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nogales</surname><given-names>C</given-names></name><etal/></person-group><article-title>Network pharmacology: curing causal mechanisms instead of treating symptoms</article-title><source>Trends Pharmacol. Sci.</source><year>2022</year><volume>43</volume><issue>2</issue><fpage>136</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2021.11.004</pub-id><pub-id pub-id-type="pmid">34895945</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Nogales, C. et al. Network pharmacology: curing causal mechanisms instead of treating symptoms. <italic toggle="yes">Trends Pharmacol. Sci.</italic><bold>43</bold> (2), 136&#8211;150. 10.1016/j.tips.2021.11.004 (2022).<pub-id pub-id-type="pmid">34895945</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tips.2021.11.004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ru</surname><given-names>J</given-names></name><etal/></person-group><article-title>TCMSP: a database of systems pharmacology for drug discovery from herbal medicines</article-title><source>J. Cheminform</source><year>2014</year><volume>6</volume><fpage>13</fpage><pub-id pub-id-type="doi">10.1186/1758-2946-6-13</pub-id><pub-id pub-id-type="pmid">24735618</pub-id><pub-id pub-id-type="pmcid">PMC4001360</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Ru, J. et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. <italic toggle="yes">J. Cheminform</italic>. <bold>6</bold>, 13. 10.1186/1758-2946-6-13 (2014).<pub-id pub-id-type="pmid">24735618</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1758-2946-6-13</pub-id><pub-id pub-id-type="pmcid">PMC4001360</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>S</given-names></name><etal/></person-group><article-title>PubChem in 2021: new data content and improved web interfaces</article-title><source>Nucleic Acids Res.</source><year>2021</year><volume>49</volume><issue>D1</issue><fpage>D1388</fpage><lpage>D1395</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa971</pub-id><pub-id pub-id-type="pmid">33151290</pub-id><pub-id pub-id-type="pmcid">PMC7778930</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Kim, S. et al. PubChem in 2021: new data content and improved web interfaces. <italic toggle="yes">Nucleic Acids Res.</italic><bold>49</bold> (D1), D1388&#8211;D1395. 10.1093/nar/gkaa971 (2021).<pub-id pub-id-type="pmid">33151290</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkaa971</pub-id><pub-id pub-id-type="pmcid">PMC7778930</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gfeller</surname><given-names>D</given-names></name><name name-style="western"><surname>Michielin</surname><given-names>O</given-names></name><name name-style="western"><surname>Zoete</surname><given-names>V</given-names></name></person-group><article-title>Shaping the interaction landscape of bioactive molecules</article-title><source>Bioinformatics</source><year>2013</year><volume>29</volume><issue>23</issue><fpage>3073</fpage><lpage>3079</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt540</pub-id><pub-id pub-id-type="pmid">24048355</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Gfeller, D., Michielin, O. &amp; Zoete, V. Shaping the interaction landscape of bioactive molecules. <italic toggle="yes">Bioinformatics</italic><bold>29</bold> (23), 3073&#8211;3079. 10.1093/bioinformatics/btt540 (2013).<pub-id pub-id-type="pmid">24048355</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bioinformatics/btt540</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="other">Stelzer, G. et al. The GeneCards Suite: From gene data mining to disease genome sequence analyses. <italic toggle="yes">Curr. Protoc. Bioinf.</italic><bold>54</bold> 1.30.1&#8211;1.30.33. 10.1002/cpbi.5. (2016).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cpbi.5</pub-id><pub-id pub-id-type="pmid">27322403</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>N</given-names></name><etal/></person-group><article-title>Network pharmacology mechanism of scutellarin to inhibit RGC pyroptosis in diabetic retinopathy</article-title><source>Sci. Rep.</source><year>2023</year><volume>13</volume><issue>1</issue><fpage>6504</fpage><pub-id pub-id-type="doi">10.1038/s41598-023-33665-3</pub-id><pub-id pub-id-type="pmid">37081038</pub-id><pub-id pub-id-type="pmcid">PMC10119430</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Li, N. et al. Network pharmacology mechanism of scutellarin to inhibit RGC pyroptosis in diabetic retinopathy. <italic toggle="yes">Sci. Rep.</italic><bold>13</bold> (1), 6504. 10.1038/s41598-023-33665-3 (2023).<pub-id pub-id-type="pmid">37081038</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-023-33665-3</pub-id><pub-id pub-id-type="pmcid">PMC10119430</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szklarczyk</surname><given-names>D</given-names></name><etal/></person-group><article-title>The STRING database in 2023: protein&#8211;protein association networks and functional enrichment analyses for any sequenced genome of interest</article-title><source>Nucleic Acids Res.</source><year>2023</year><volume>51</volume><issue>D1</issue><fpage>5D638</fpage><lpage>D646</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac1000</pub-id><pub-id pub-id-type="pmcid">PMC9825434</pub-id><pub-id pub-id-type="pmid">36370105</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Szklarczyk, D. et al. The STRING database in 2023: protein&#8211;protein association networks and functional enrichment analyses for any sequenced genome of interest. <italic toggle="yes">Nucleic Acids Res.</italic><bold>51</bold> (D1), 5D638&#8211;D646. 10.1093/nar/gkac1000 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkac1000</pub-id><pub-id pub-id-type="pmcid">PMC9825434</pub-id><pub-id pub-id-type="pmid">36370105</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="other">Rubach, P., Zajac, S., Jastrzebski, B., Sulkowska, J. I. &amp; Su&#322;kowski, P. Genus for biomolecules. <italic toggle="yes">Nucleic Acids Res.</italic><bold>48</bold> (D1), D1129-D1135. 10.1093/nar/gkz845 (2020). <pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkz845</pub-id><pub-id pub-id-type="pmcid">PMC6943057</pub-id><pub-id pub-id-type="pmid">31584078</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okuyama</surname><given-names>E</given-names></name><etal/></person-group><article-title>Analgesic components of Saposhnikovia root (<italic toggle="yes">Saposhnikovia divaricata</italic>)</article-title><source>Chem. Pharm. Bull. (Tokyo)</source><year>2001</year><volume>49</volume><issue>2</issue><fpage>154</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1248/cpb.49.154</pub-id><pub-id pub-id-type="pmid">11217101</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Okuyama, E. et al. Analgesic components of Saposhnikovia root (<italic toggle="yes">Saposhnikovia divaricata</italic>). <italic toggle="yes">Chem. Pharm. Bull. (Tokyo)</italic>. <bold>49</bold> (2), 154&#8211;160. 10.1248/cpb.49.154 (2001).<pub-id pub-id-type="pmid">11217101</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1248/cpb.49.154</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>ZY</given-names></name><etal/></person-group><article-title>Neuroprotective effects of total saikosaponins of Bupleurum Yinchowense on corticosterone-induced apoptosis in PC12 cells</article-title><source>J. Ethnopharmacol.</source><year>2013</year><volume>48</volume><issue>3</issue><fpage>794</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2013.04.057</pub-id><pub-id pub-id-type="pmid">23694845</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Li, Z. Y. et al. Neuroprotective effects of total saikosaponins of Bupleurum Yinchowense on corticosterone-induced apoptosis in PC12 cells. <italic toggle="yes">J. Ethnopharmacol.</italic><bold>48</bold> (3), 794&#8211;803. 10.1016/j.jep.2013.04.057 (2013).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jep.2013.04.057</pub-id><pub-id pub-id-type="pmid">23694845</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Saposhnikovia divaricata-An ethnopharmacological, phytochemical and pharmacological review</article-title><source>Chin. J. Integr. Med.</source><year>2020</year><volume>26</volume><issue>11</issue><fpage>873</fpage><lpage>880</lpage><pub-id pub-id-type="doi">10.1007/s11655-020-3091-x</pub-id><pub-id pub-id-type="pmid">32328867</pub-id><pub-id pub-id-type="pmcid">PMC7176574</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Yang, M. et al. Saposhnikovia divaricata-An ethnopharmacological, phytochemical and pharmacological review. <italic toggle="yes">Chin. J. Integr. Med.</italic><bold>26</bold> (11), 873&#8211;880. 10.1007/s11655-020-3091-x (2020).<pub-id pub-id-type="pmid">32328867</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11655-020-3091-x</pub-id><pub-id pub-id-type="pmcid">PMC7176574</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Urbagarova</surname><given-names>BM</given-names></name><etal/></person-group><article-title>Chromones and coumarins from <italic toggle="yes">Saposhnikovia divaricata</italic> (Turcz.) schischk. Growing in Buryatia and Mongolia and their cytotoxicity</article-title><source>J. Ethnopharmacol.</source><year>2020</year><volume>261</volume><fpage>112517</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2019.112517</pub-id><pub-id pub-id-type="pmid">31931162</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Urbagarova, B. M. et al. Chromones and coumarins from <italic toggle="yes">Saposhnikovia divaricata</italic> (Turcz.) schischk. Growing in Buryatia and Mongolia and their cytotoxicity. <italic toggle="yes">J. Ethnopharmacol.</italic><bold>261</bold>, 112517. 10.1016/j.jep.2019.112517 (2020).<pub-id pub-id-type="pmid">31931162</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jep.2019.112517</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mochizuki</surname><given-names>H</given-names></name></person-group><article-title>Arsenic neurotoxicity in humans</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><issue>14</issue><fpage>3418</fpage><pub-id pub-id-type="doi">10.3390/ijms20143418</pub-id><pub-id pub-id-type="pmid">31336801</pub-id><pub-id pub-id-type="pmcid">PMC6678206</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Mochizuki, H. Arsenic neurotoxicity in humans. <italic toggle="yes">Int. J. Mol. Sci.</italic><bold>20</bold> (14), 3418. 10.3390/ijms20143418 (2019).<pub-id pub-id-type="pmid">31336801</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms20143418</pub-id><pub-id pub-id-type="pmcid">PMC6678206</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>X</given-names></name><etal/></person-group><article-title>The PI3K/AKT signalling pathway in inflammation, cell death and glial Scar formation after traumatic spinal cord injury: mechanisms and therapeutic opportunities</article-title><source>Cell. Prolif.</source><year>2022</year><volume>55</volume><issue>9</issue><fpage>e13275</fpage><pub-id pub-id-type="doi">10.1111/cpr.13275</pub-id><pub-id pub-id-type="pmid">35754255</pub-id><pub-id pub-id-type="pmcid">PMC9436900</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">He, X. et al. The PI3K/AKT signalling pathway in inflammation, cell death and glial Scar formation after traumatic spinal cord injury: mechanisms and therapeutic opportunities. <italic toggle="yes">Cell. Prolif.</italic><bold>55</bold> (9), e13275. 10.1111/cpr.13275 (2022).<pub-id pub-id-type="pmid">35754255</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/cpr.13275</pub-id><pub-id pub-id-type="pmcid">PMC9436900</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ariafar</surname><given-names>S</given-names></name><name name-style="western"><surname>Makhdoomi</surname><given-names>S</given-names></name><name name-style="western"><surname>Mohammadi</surname><given-names>M</given-names></name></person-group><article-title>Arsenic and Tau phosphorylation: a mechanistic review</article-title><source>Biol. Trace Elem. Res.</source><year>2023</year><volume>201</volume><issue>12</issue><fpage>5708</fpage><lpage>5720</lpage><pub-id pub-id-type="doi">10.1007/s12011-023-03634-y</pub-id><pub-id pub-id-type="pmid">37211576</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Ariafar, S., Makhdoomi, S. &amp; Mohammadi, M. Arsenic and Tau phosphorylation: a mechanistic review. <italic toggle="yes">Biol. Trace Elem. Res.</italic><bold>201</bold> (12), 5708&#8211;5720. 10.1007/s12011-023-03634-y (2023).<pub-id pub-id-type="pmid">37211576</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12011-023-03634-y</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Arsenic (III) and/or copper (II) induces oxidative stress in chicken brain and subsequent effects on mitochondrial homeostasis and autophagy</article-title><source>J. Inorg. Biochem.</source><year>2020</year><volume>211</volume><fpage>111201</fpage><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2020.111201</pub-id><pub-id pub-id-type="pmid">32805460</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Liu, Y. et al. Arsenic (III) and/or copper (II) induces oxidative stress in chicken brain and subsequent effects on mitochondrial homeostasis and autophagy. <italic toggle="yes">J. Inorg. Biochem.</italic><bold>211</bold>, 111201. 10.1016/j.jinorgbio.2020.111201 (2020).<pub-id pub-id-type="pmid">32805460</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jinorgbio.2020.111201</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="other">Fan, T. J., Han, L. H., Cong, R. S. &amp; Liang, J. Caspase family proteases and apoptosis, acta biochim biophys sin (Shanghai). <bold>37</bold>(11) 719&#8211;727. 10.1111/j.1745-7270.2005.00108.x (2005).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1745-7270.2005.00108.x</pub-id><pub-id pub-id-type="pmid">16270150</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>Q</given-names></name><etal/></person-group><article-title>ATF3 promotes Arsenic-Induced apoptosis and oppositely regulates DR5 and Bcl-xL expression in human bronchial epithelial cells</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><issue>8</issue><fpage>4223</fpage><pub-id pub-id-type="doi">10.3390/ijms22084223</pub-id><pub-id pub-id-type="pmid">33921748</pub-id><pub-id pub-id-type="pmcid">PMC8072958</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Shi, Q. et al. ATF3 promotes Arsenic-Induced apoptosis and oppositely regulates DR5 and Bcl-xL expression in human bronchial epithelial cells. <italic toggle="yes">Int. J. Mol. Sci.</italic><bold>22</bold> (8), 4223. 10.3390/ijms22084223 (2021).<pub-id pub-id-type="pmid">33921748</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms22084223</pub-id><pub-id pub-id-type="pmcid">PMC8072958</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohammadpour-Gharehbagh</surname><given-names>A</given-names></name><etal/></person-group><article-title>Genetic and epigenetic analysis of the BAX and BCL2 in the placenta of pregnant women complicated by preeclampsia</article-title><source>Apoptosis</source><year>2019</year><volume>24</volume><issue>3&#8211;4</issue><fpage>301</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1007/s10495-018-1501-8</pub-id><pub-id pub-id-type="pmid">30701356</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Mohammadpour-Gharehbagh, A. et al. Genetic and epigenetic analysis of the BAX and BCL2 in the placenta of pregnant women complicated by preeclampsia. <italic toggle="yes">Apoptosis</italic>. <bold>24</bold> (3&#8211;4), 301&#8211;311. 10.1007/s10495-018-1501-8 (2019).<pub-id pub-id-type="pmid">30701356</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10495-018-1501-8</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Renault</surname><given-names>TT</given-names></name><etal/></person-group><article-title>Mitochondrial shape governs BAX-induced membrane permeabilization and apoptosis</article-title><source>Mol. Cell.</source><year>2015</year><volume>57</volume><issue>1</issue><fpage>69</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2014.10.028</pub-id><pub-id pub-id-type="pmid">25482509</pub-id><pub-id pub-id-type="pmcid">PMC4289414</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Renault, T. T. et al. Mitochondrial shape governs BAX-induced membrane permeabilization and apoptosis. <italic toggle="yes">Mol. Cell.</italic><bold>57</bold> (1), 69&#8211;82. 10.1016/j.molcel.2014.10.028 (2015).<pub-id pub-id-type="pmid">25482509</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2014.10.028</pub-id><pub-id pub-id-type="pmcid">PMC4289414</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Renault</surname><given-names>TT</given-names></name><name name-style="western"><surname>Floros</surname><given-names>KV</given-names></name><name name-style="western"><surname>Chipuk</surname><given-names>JE</given-names></name></person-group><article-title>BAK/BAX activation and cytochrome c release assays using isolated mitochondria</article-title><source>Methods</source><year>2013</year><volume>61</volume><issue>2</issue><fpage>146</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2013.03.030</pub-id><pub-id pub-id-type="pmid">23567751</pub-id><pub-id pub-id-type="pmcid">PMC3686896</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Renault, T. T., Floros, K. V. &amp; Chipuk, J. E. BAK/BAX activation and cytochrome c release assays using isolated mitochondria. <italic toggle="yes">Methods</italic>. <bold>61</bold> (2), 146&#8211;155. 10.1016/j.ymeth.2013.03.030 (2013).<pub-id pub-id-type="pmid">23567751</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ymeth.2013.03.030</pub-id><pub-id pub-id-type="pmcid">PMC3686896</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sirtl</surname><given-names>S</given-names></name><etal/></person-group><article-title>Hypertonicity-enforced BCL-2 addiction unleashes the cytotoxic potential of death receptors</article-title><source>Oncogene</source><year>2018</year><volume>37</volume><issue>30</issue><fpage>4122</fpage><lpage>4136</lpage><pub-id pub-id-type="doi">10.1038/s41388-018-0265-5</pub-id><pub-id pub-id-type="pmid">29706657</pub-id><pub-id pub-id-type="pmcid">PMC6062497</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Sirtl, S. et al. Hypertonicity-enforced BCL-2 addiction unleashes the cytotoxic potential of death receptors. <italic toggle="yes">Oncogene</italic>. <bold>37</bold> (30), 4122&#8211;4136. 10.1038/s41388-018-0265-5 (2018).<pub-id pub-id-type="pmid">29706657</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41388-018-0265-5</pub-id><pub-id pub-id-type="pmcid">PMC6062497</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Chemotherapy drugs induce pyroptosis through caspase&#8211;3 cleavage of a gasdermin</article-title><source>Nature</source><year>2017</year><volume>547</volume><issue>7661</issue><fpage>99</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1038/nature22393</pub-id><pub-id pub-id-type="pmid">28459430</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Wang, Y. et al. Chemotherapy drugs induce pyroptosis through caspase&#8211;3 cleavage of a gasdermin. <italic toggle="yes">Nature</italic><bold>547</bold> (7661), 99&#8211;103. 10.1038/nature22393 (2017).<pub-id pub-id-type="pmid">28459430</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature22393</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Discovery of a potent Hedgehog pathway inhibitor capable of activating caspase8-dependent apoptosis</article-title><source>J. Pharmacol. Sci.</source><year>2018</year><volume>137</volume><issue>3</issue><fpage>256</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1016/j.jphs.2018.07.001</pub-id><pub-id pub-id-type="pmid">30064819</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Chen, Q. et al. Discovery of a potent Hedgehog pathway inhibitor capable of activating caspase8-dependent apoptosis. <italic toggle="yes">J. Pharmacol. Sci.</italic><bold>137</bold> (3), 256&#8211;264. 10.1016/j.jphs.2018.07.001 (2018).<pub-id pub-id-type="pmid">30064819</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jphs.2018.07.001</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><etal/></person-group><article-title>Ropivacaine promotes apoptosis of hepatocellular carcinoma cells through damaging mitochondria and activating caspase&#8211;3 activity</article-title><source>Biol. Res.</source><year>2019</year><volume>52</volume><issue>1</issue><fpage>36</fpage><pub-id pub-id-type="doi">10.1186/s40659-019-0242-7</pub-id><pub-id pub-id-type="pmid">31300048</pub-id><pub-id pub-id-type="pmcid">PMC6625015</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Wang, W. et al. Ropivacaine promotes apoptosis of hepatocellular carcinoma cells through damaging mitochondria and activating caspase&#8211;3 activity. <italic toggle="yes">Biol. Res.</italic><bold>52</bold> (1), 36. 10.1186/s40659-019-0242-7 (2019).<pub-id pub-id-type="pmid">31300048</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40659-019-0242-7</pub-id><pub-id pub-id-type="pmcid">PMC6625015</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mandal</surname><given-names>R</given-names></name><name name-style="western"><surname>Barr&#243;n</surname><given-names>JC</given-names></name><name name-style="western"><surname>Kostova</surname><given-names>I</given-names></name><name name-style="western"><surname>Becker</surname><given-names>S</given-names></name><name name-style="western"><surname>Strebhardt</surname><given-names>K</given-names></name></person-group><article-title>Caspase&#8211;8: the double-edged sword</article-title><source>Biochim. Biophys. Acta Rev. Cancer</source><year>2020</year><volume>1873</volume><issue>2</issue><fpage>188357</fpage><pub-id pub-id-type="doi">10.1016/j.bbcan.2020.188357</pub-id><pub-id pub-id-type="pmid">32147543</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Mandal, R., Barr&#243;n, J. C., Kostova, I., Becker, S. &amp; Strebhardt, K. Caspase&#8211;8: the double-edged sword. <italic toggle="yes">Biochim. Biophys. Acta Rev. Cancer</italic>. <bold>1873</bold> (2), 188357. 10.1016/j.bbcan.2020.188357 (2020).<pub-id pub-id-type="pmid">32147543</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbcan.2020.188357</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Powley</surname><given-names>IR</given-names></name><name name-style="western"><surname>Hughes</surname><given-names>MA</given-names></name><name name-style="western"><surname>Cain</surname><given-names>K</given-names></name><name name-style="western"><surname>MacFarlane</surname><given-names>M</given-names></name></person-group><article-title>Caspase&#8211;8 tyrosine&#8211;380 phosphorylation inhibits CD95 DISC function by preventing procaspase&#8211;8 maturation and cycling within the complex</article-title><source>Oncogene</source><year>2016</year><volume>35</volume><issue>43</issue><fpage>5629</fpage><lpage>5640</lpage><pub-id pub-id-type="doi">10.1038/onc.2016.99</pub-id><pub-id pub-id-type="pmid">27109099</pub-id><pub-id pub-id-type="pmcid">PMC5095593</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Powley, I. R., Hughes, M. A., Cain, K. &amp; MacFarlane, M. Caspase&#8211;8 tyrosine&#8211;380 phosphorylation inhibits CD95 DISC function by preventing procaspase&#8211;8 maturation and cycling within the complex. <italic toggle="yes">Oncogene</italic>. <bold>35</bold> (43), 5629&#8211;5640. 10.1038/onc.2016.99 (2016).<pub-id pub-id-type="pmid">27109099</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/onc.2016.99</pub-id><pub-id pub-id-type="pmcid">PMC5095593</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clark</surname><given-names>RS</given-names></name><etal/></person-group><article-title>Caspase&#8211;3 mediated neuronal death after traumatic brain injury in rats</article-title><source>J. Neurochem</source><year>2000</year><volume>74</volume><issue>2</issue><fpage>740</fpage><lpage>753</lpage><pub-id pub-id-type="doi">10.1046/j.1471-4159.2000.740740.x</pub-id><pub-id pub-id-type="pmid">10646526</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Clark, R. S. et al. Caspase&#8211;3 mediated neuronal death after traumatic brain injury in rats. <italic toggle="yes">J. Neurochem</italic>. <bold>74</bold> (2), 740&#8211;753. 10.1046/j.1471-4159.2000.740740.x (2000).<pub-id pub-id-type="pmid">10646526</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1471-4159.2000.740740.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Arsenic trioxide sensitizes pancreatic cancer cells to gemcitabine through downregulation of the TIMP1/PI3K/AKT/mTOR axis</article-title><source>Transl. Res.</source><year>2023</year><volume>255</volume><fpage>66</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.trsl.2022.11.007</pub-id><pub-id pub-id-type="pmid">36400307</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Tian, Z. et al. Arsenic trioxide sensitizes pancreatic cancer cells to gemcitabine through downregulation of the TIMP1/PI3K/AKT/mTOR axis. <italic toggle="yes">Transl. Res.</italic><bold>255</bold>, 66&#8211;76. 10.1016/j.trsl.2022.11.007 (2023).<pub-id pub-id-type="pmid">36400307</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.trsl.2022.11.007</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Puerarin inhibited oxidative stress and alleviated cerebral ischemia-reperfusion injury through PI3K/Akt/Nrf2 signaling pathway</article-title><source>Front. Pharmacol.</source><year>2023</year><volume>14</volume><fpage>1134380</fpage><pub-id pub-id-type="doi">10.3389/fphar.2023.1134380</pub-id><pub-id pub-id-type="pmid">37284311</pub-id><pub-id pub-id-type="pmcid">PMC10240043</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Zhang, Q. et al. Puerarin inhibited oxidative stress and alleviated cerebral ischemia-reperfusion injury through PI3K/Akt/Nrf2 signaling pathway. <italic toggle="yes">Front. Pharmacol.</italic><bold>14</bold>, 1134380. 10.3389/fphar.2023.1134380 (2023).<pub-id pub-id-type="pmid">37284311</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fphar.2023.1134380</pub-id><pub-id pub-id-type="pmcid">PMC10240043</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>